BioAtla Inc. (BCAB) PT Lowered to $68 at Jefferies After Meeting with Management
Tweet Send to a Friend
Jefferies analyst Kelly Shi lowered the price target on BioAtla Inc. (NASDAQ: BCAB) to $68.00 (from $75.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
